Wolverine Trading
FBIO icon

Wolverine Trading’s Fortress Biotech FBIO Stock Holding History

Wolverine Trading’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,156
Closed -$26.5K – 5067
2024
Q4 		$26.5K Buy
+12,156
New +$22K ﹤0.01% 5080
2022
Q1 		– Sell
-1,485
Closed -$56K – 5698
2021
Q4 		$56K Buy
1,485
+571
+62% +$25.5K ﹤0.01% 5291
2021
Q3 		$49K Buy
+914
New +$44.6K ﹤0.01% 6020
2018
Q4 		– Sell
-943
Closed -$23K – 4680
2018
Q3 		$23K Buy
+943
New +$30.2K ﹤0.01% 4791
2017
Q1 		– Sell
-1,333
Closed -$54K – 4487
2016
Q4 		$54K Sell
1,333
-287
-18% -$10.7K ﹤0.01% 4197
2016
Q3 		$69K Buy
+1,620
New +$68.9K ﹤0.01% 4329

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Wolverine Trading's FBIO Position: Q1 2025 in Review

Wolverine Trading sold out of Fortress Biotech (FBIO) in Q1 2025, closing a stake of 12,156 shares — an estimated $26.5K sold.

Wolverine Trading first reported a position in FBIO in Q3 2016 and held it in 6 quarters. The position peaked at $69K in Q3 2016. 46 funds tracked by Wall St. Rank hold FBIO as of Q1 2025.

  • Wolverine Trading reported no remaining Fortress Biotech position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,156 Fortress Biotech shares in Q1 2025, an estimated $26.5K.
  • Wolverine Trading first reported a position in Fortress Biotech in Q3 2016 and held it in 6 quarters.
  • Wolverine Trading's Fortress Biotech position peaked at $69K in Q3 2016.
  • 46 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.